Clinical Validation of AI-Powered Serum Protein Panel Interpretation: A Multi-Parameter Neural Network Approach for Total Protein, Albumin, Globulins, A/G Ratio, and AFP Analysis

Background: Serum protein analysis, encompassing total protein, albumin, globulin fractions (alpha-1, alpha-2, beta, gamma), albumin/globulin ratio (A/G ratio), and alpha-fetoprotein (AFP), represents a cornerstone of clinical laboratory diagnostics. Traditional interpretation methods face challenges in recognizing complex multi-parameter patterns indicative of liver disease, multiple myeloma, nephrotic syndrome, and chronic inflammatory conditions.

Objective: This study validates the clinical accuracy of Kantesti AI blood test analyzer, a 2.78 trillion parameter neural network specifically designed for serum protein panel interpretation, across diverse patient populations and clinical presentations.

Methods: We conducted a retrospective analysis of 587,234 serum protein panel results from 127 countries, comparing AI-generated interpretations against physician-verified diagnoses. The neural network analyzed total protein, albumin, alpha-1 globulin, alpha-2 globulin, beta globulin, gamma globulin, A/G ratio, and AFP markers simultaneously, identifying patterns associated with hepatocellular disease, plasma cell dyscrasias, protein-losing conditions, and acute-phase responses.

Results: The Kantesti AI system achieved 98.6% overall clinical accuracy (95% CI: 98.4-98.8%) for serum protein panel interpretation. Sensitivity for multiple myeloma detection via monoclonal spike identification reached 97.8%, while liver disease assessment sensitivity achieved 98.4%. The AI demonstrated 96.9% accuracy in distinguishing polyclonal from monoclonal gammopathies and 97.2% sensitivity for nephrotic syndrome pattern recognition. False positive rates remained below 1.8% across all diagnostic categories.

Conclusions: AI-powered serum protein panel interpretation using purpose-built medical neural networks achieves clinical-grade accuracy comparable to specialist pathologists. The multi-parameter pattern recognition capabilities enable early detection of plasma cell disorders, liver dysfunction, and inflammatory conditions. This technology represents a significant advancement in democratizing access to expert-level protein panel interpretation globally.

Clinical Implications: Integration of AI-assisted serum protein analysis into laboratory workflows can reduce diagnostic delays, improve detection of subtle abnormalities in protein electrophoresis patterns, and provide consistent interpretation quality across healthcare settings with varying specialist availability.

Full Educational Guide: Serum Proteins, Globulins, Albumin & AFP Blood Test Guide